Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Space
Go back to Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Space| TELEFLEX INCORPORATED (NYSE: TFX) | Delayed: 130.96 -1.19 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $132.15 | 52 Week High | $188.79 | |||
| Open | $131.75 | 52 Week Low | $125.28 | |||
| Day High | $132.36 | P/E | 37.85 | |||
| Day Low | $129.51 | EPS | $3.46 | |||
| Volume | 218,397 | |||||
